Unknown

Dataset Information

0

IL-28B/IFN-lambda 3 drives granzyme B loading and significantly increases CTL killing activity in macaques.


ABSTRACT: Type III/lambda interferons (IFNs) were discovered less than a decade ago and are still in the process of being characterized. Although previous studies have focused on the function of IFN-lambda 3 (also known as interleukin (IL)-28B) in a small animal model, it is unknown whether these functions would translate to a larger, more relevant model. Thus in the present study, we have used DNA vaccination as a method of studying the influence of IFN-lambda 3 on adaptive immune responses in rhesus macaques. Results of our study show for the first time that IFN-lambda 3 has significant influence on antigen-specific CD8(+) T-cell function, especially in regards to cytotoxicity. Peripheral CD8(+) T cells from animals that were administered IFN-lambda 3 showed substantially increased cytotoxic responses as gauged by CD107a and granzyme B coexpression as well as perforin release. Moreover, CD8(+) T cells isolated from the mesenteric lymph nodes (MLN) of animals receiving IFN-lambda 3 loaded significant amounts of granzyme B upon extended antigenic stimulation and induced significantly more granzyme B-mediated cell death of peptide pulsed targets. These data suggest that IFN-lambda 3 is a potent effector of the immune system with special emphasis on CD8(+) T-cell killing functions which warrants further study as a possible immunoadjuvant.

SUBMITTER: Morrow MP 

PROVIDER: S-EPMC2956930 | biostudies-literature | 2010 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

IL-28B/IFN-lambda 3 drives granzyme B loading and significantly increases CTL killing activity in macaques.

Morrow Matthew P MP   Yan Jian J   Pankhong Panyupa P   Shedlock Devon J DJ   Lewis Mark G MG   Talbott Kendra K   Toporovski Roberta R   Khan Amir S AS   Sardesai Niranjan Y NY   Weiner David B DB  

Molecular therapy : the journal of the American Society of Gene Therapy 20100622 9


Type III/lambda interferons (IFNs) were discovered less than a decade ago and are still in the process of being characterized. Although previous studies have focused on the function of IFN-lambda 3 (also known as interleukin (IL)-28B) in a small animal model, it is unknown whether these functions would translate to a larger, more relevant model. Thus in the present study, we have used DNA vaccination as a method of studying the influence of IFN-lambda 3 on adaptive immune responses in rhesus mac  ...[more]

Similar Datasets

| S-EPMC3667352 | biostudies-literature
| S-EPMC4624722 | biostudies-literature
| S-EPMC2715871 | biostudies-literature
| S-EPMC3974637 | biostudies-literature
| S-EPMC2265414 | biostudies-literature
| S-EPMC4168979 | biostudies-literature
| S-EPMC11601549 | biostudies-literature
| S-EPMC4180868 | biostudies-literature
| S-EPMC6529452 | biostudies-literature
| S-EPMC5510750 | biostudies-literature